Compile Data Set for Download or QSAR
Report error Found 60 Enz. Inhib. hit(s) with all data for entry = 9312
TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459357(CHEMBL4207047 | US10751335, Example 26)
Affinity DataEC50:  36nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50518035(CHEMBL4452384 | US10751335, Example 16)
Affinity DataEC50:  83nMAssay Description:he CisBio cAMP cell based assay kit that uses HTRF technology was utilized to assess MOR-mediated inhibition of cAMP. Assays were performed according...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459348(CHEMBL4216968 | US10751335, Example 17)
Affinity DataEC50:  58nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459388(CHEMBL4204767 | US10751335, Example 18)
Affinity DataEC50:  140nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459388(CHEMBL4204767 | US10751335, Example 18)
Affinity DataEC50:  119nMAssay Description:he CisBio cAMP cell based assay kit that uses HTRF technology was utilized to assess MOR-mediated inhibition of cAMP. Assays were performed according...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457857(5-chloro-1-(1-(1-(4-(difluoromethoxy)phenyl)ethyl)...)
Affinity DataEC50:  15nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457858(4-chloro-1-(1-(1-(4-(trifluoromethoxy)phenyl)ethyl...)
Affinity DataEC50:  30nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457859(6-chloro-1-(1-(1-(4-chloro-2-fluorophenyl)ethyl)pi...)
Affinity DataEC50:  14nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457859(6-chloro-1-(1-(1-(4-chloro-2-fluorophenyl)ethyl)pi...)
Affinity DataEC50:  3nMAssay Description:he CisBio cAMP cell based assay kit that uses HTRF technology was utilized to assess MOR-mediated inhibition of cAMP. Assays were performed according...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457860(6-bromo-1-(1-(1-(4-(trifluoromethoxy)phenyl)ethyl)...)
Affinity DataEC50:  39nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457861(6-bromo-1-(1-(1-(4-chloro-2-fluorophenyl)ethyl)pip...)
Affinity DataEC50:  21nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457862(4,6-dichloro-1-(1-(1-(4-methoxyphenyl)ethyl)piperi...)
Affinity DataEC50:  0.400nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457862(4,6-dichloro-1-(1-(1-(4-methoxyphenyl)ethyl)piperi...)
Affinity DataEC50:  0.400nMAssay Description:he CisBio cAMP cell based assay kit that uses HTRF technology was utilized to assess MOR-mediated inhibition of cAMP. Assays were performed according...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457863(5,6-dichloro-1-(1-(2-fluoro-4-methylbenzyl)piperid...)
Affinity DataEC50:  66nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457863(5,6-dichloro-1-(1-(2-fluoro-4-methylbenzyl)piperid...)
Affinity DataEC50:  32nMAssay Description:he CisBio cAMP cell based assay kit that uses HTRF technology was utilized to assess MOR-mediated inhibition of cAMP. Assays were performed according...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50518035(CHEMBL4452384 | US10751335, Example 16)
Affinity DataEC50:  122nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459357(CHEMBL4207047 | US10751335, Example 26)
Affinity DataEC50:  55nMAssay Description:he CisBio cAMP cell based assay kit that uses HTRF technology was utilized to assess MOR-mediated inhibition of cAMP. Assays were performed according...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457865(4-chloro-1-(1-(1-(4-chlorophenyl)ethyl)piperidin-4...)
Affinity DataEC50:  3.10nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457865(4-chloro-1-(1-(1-(4-chlorophenyl)ethyl)piperidin-4...)
Affinity DataEC50:  3nMAssay Description:he CisBio cAMP cell based assay kit that uses HTRF technology was utilized to assess MOR-mediated inhibition of cAMP. Assays were performed according...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457866(1-(1-(2-chlorobenzyl)piperidin-4-yl)-3-(cyclopropy...)
Affinity DataEC50:  558nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457866(1-(1-(2-chlorobenzyl)piperidin-4-yl)-3-(cyclopropy...)
Affinity DataEC50:  253nMAssay Description:he CisBio cAMP cell based assay kit that uses HTRF technology was utilized to assess MOR-mediated inhibition of cAMP. Assays were performed according...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457867(5-chloro-3-(cyclopropylmethyl)-1-(1-(1-(p-tolyl)et...)
Affinity DataEC50:  12nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459363(CHEMBL4202958 | US10751335, Example 4)
Affinity DataEC50:  220nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457843(5-chloro-1-(1-(1-(4-(ethylthio)phenyl)ethyl)piperi...)
Affinity DataEC50:  291nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459352(CHEMBL4217435 | US10751335, Example 15)
Affinity DataEC50:  129nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459357(CHEMBL4207047 | US10751335, Example 26)
Affinity DataEC50:  36nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459363(CHEMBL4202958 | US10751335, Example 4)
Affinity DataEC50:  950nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457843(5-chloro-1-(1-(1-(4-(ethylthio)phenyl)ethyl)piperi...)
Affinity DataEC50:  300nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459352(CHEMBL4217435 | US10751335, Example 15)
Affinity DataEC50:  350nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459357(CHEMBL4207047 | US10751335, Example 26)
Affinity DataEC50:  540nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457846(6-bromo-1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-y...)
Affinity DataEC50:  1nMAssay Description:he CisBio cAMP cell based assay kit that uses HTRF technology was utilized to assess MOR-mediated inhibition of cAMP. Assays were performed according...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459364(CHEMBL4210060 | US10751335, Example 1)
Affinity DataEC50:  89nMAssay Description:he CisBio cAMP cell based assay kit that uses HTRF technology was utilized to assess MOR-mediated inhibition of cAMP. Assays were performed according...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457840(1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-d...)
Affinity DataEC50:  16nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457840(1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-d...)
Affinity DataEC50:  7nMAssay Description:he CisBio cAMP cell based assay kit that uses HTRF technology was utilized to assess MOR-mediated inhibition of cAMP. Assays were performed according...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457841(US10751335, Example 3 | 1-(1-(1-(4-bromo-2-fluorop...)
Affinity DataEC50:  43nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457841(US10751335, Example 3 | 1-(1-(1-(4-bromo-2-fluorop...)
Affinity DataEC50:  30nMAssay Description:he CisBio cAMP cell based assay kit that uses HTRF technology was utilized to assess MOR-mediated inhibition of cAMP. Assays were performed according...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459363(CHEMBL4202958 | US10751335, Example 4)
Affinity DataEC50:  223nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459363(CHEMBL4202958 | US10751335, Example 4)
Affinity DataEC50:  319nMAssay Description:he CisBio cAMP cell based assay kit that uses HTRF technology was utilized to assess MOR-mediated inhibition of cAMP. Assays were performed according...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457843(5-chloro-1-(1-(1-(4-(ethylthio)phenyl)ethyl)piperi...)
Affinity DataEC50:  291nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457843(5-chloro-1-(1-(1-(4-(ethylthio)phenyl)ethyl)piperi...)
Affinity DataEC50:  622nMAssay Description:he CisBio cAMP cell based assay kit that uses HTRF technology was utilized to assess MOR-mediated inhibition of cAMP. Assays were performed according...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457844(1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-6-chl...)
Affinity DataEC50:  2nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457844(1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-6-chl...)
Affinity DataEC50:  1nMAssay Description:he CisBio cAMP cell based assay kit that uses HTRF technology was utilized to assess MOR-mediated inhibition of cAMP. Assays were performed according...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457841(US10751335, Example 3 | 1-(1-(1-(4-bromo-2-fluorop...)
Affinity DataEC50:  33nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457841(US10751335, Example 3 | 1-(1-(1-(4-bromo-2-fluorop...)
Affinity DataEC50:  25nMAssay Description:he CisBio cAMP cell based assay kit that uses HTRF technology was utilized to assess MOR-mediated inhibition of cAMP. Assays were performed according...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457846(6-bromo-1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-y...)
Affinity DataEC50:  2.5nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM50459364(CHEMBL4210060 | US10751335, Example 1)
Affinity DataEC50:  67nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457847(6-chloro-1-(1-(1-(4-(trifluoromethyl)phenyl)ethyl)...)
Affinity DataEC50:  45nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457847(6-chloro-1-(1-(1-(4-(trifluoromethyl)phenyl)ethyl)...)
Affinity DataEC50:  35nMAssay Description:he CisBio cAMP cell based assay kit that uses HTRF technology was utilized to assess MOR-mediated inhibition of cAMP. Assays were performed according...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457848(5-chloro-1-(1-(1-(4-(trifluoromethyl)phenyl)ethyl)...)
Affinity DataEC50:  279nMAssay Description:A standard [35S]GTPγS binding assay in membranes prepared from CHO cells expressing the human MOR was performed in a concentration response mann...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetMu-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM457848(5-chloro-1-(1-(1-(4-(trifluoromethyl)phenyl)ethyl)...)
Affinity DataEC50:  258nMAssay Description:he CisBio cAMP cell based assay kit that uses HTRF technology was utilized to assess MOR-mediated inhibition of cAMP. Assays were performed according...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

Displayed 1 to 50 (of 60 total ) | Next | Last >>
Jump to: